Nazione: Svizzera
Lingua: italiano
Fonte: Swissmedic (Swiss Agency for Therapeutic Products)
tamsulosinum
Mepha Pharma AG
G04CA02
tamsulosinum
Retardtabletten
tamsulosini hydrochloridum 0.4 mg corresp. tamsulosinum 0.367 mg, cellulosum microcristallinum, polyethyleni oxidum cum E 321, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 8000, E 171, E 172 (flavum), E 172 (rubrum), pro compresso obducto.
B
Synthetika
iperplasia prostatica Benigna
zugelassen
2011-10-03